What should you know about the Johnson & Johnson split?

Johnson & Johnson (NYSE: JNJ) stock is on the move Friday after the company announced split plans that would create two public companies. Let’s take a look at what investors need to know about the JNJ split below! The split would result in a new Johnson & Johnson as well as a still-unnamed consumer health company.

What investors need to know about the JNJ split?

Let’s take a look at what investors need to know about the JNJ split below! The split would result in a new Johnson & Johnson as well as a still-unnamed consumer health company. That new company would have a focus on global consumer health. This would see it manage the Neutrogena, Tylenol, Listerine, and other consumer health brands owned by JNJ.

Did Johnson & Johnson change its business structure?

Learn More The company recently announced a major change to its business structure. When Johnson & Johnson ( JNJ 0.05%) announced that it would be splitting its pharmaceutical and medical device businesses from its consumer health segment last month, investors were stunned.

Will Johnson & Johnson break up?

Johnson & Johnson, with headquarters in New Jersey, is part of a parade of once-proud companies that have recently unveiled plans to break themselves up or radically shrink. This week alone, the industrial conglomerates General Electric and Toshiba announced that they would split up.